Global Influenza Vaccine Market Insights and Forecast to 2027

Global Influenza Vaccine Market Insights and Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Whole Virus Vaccines
1.4.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Market by Application
1.3.1 Global Influenza Vaccine Market Size Growth Rate by Application
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Influenza Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Influenza Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Influenza Vaccine Regions by Sales
2.4.1 Global Top Influenza Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Influenza Vaccine Regions by Sales (2022-2027)
2.5 Global Top Influenza Vaccine Regions by Revenue
2.5.1 Global Top Influenza Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Influenza Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Influenza Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Influenza Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Sales in 2020
3.2 Global Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Top Influenza Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Influenza Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Influenza Vaccine Revenue in 2020
3.3 Global Influenza Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Influenza Vaccine Sales by Type
4.1.1 Global Influenza Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Influenza Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Influenza Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Influenza Vaccine Revenue by Type
4.2.1 Global Influenza Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Influenza Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Influenza Vaccine Price by Type
4.3.1 Global Influenza Vaccine Price by Type (2016-2021)
4.3.2 Global Influenza Vaccine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Influenza Vaccine Sales by Application
5.1.1 Global Influenza Vaccine Historical Sales by Application (2016-2021)
5.1.2 Global Influenza Vaccine Forecasted Sales by Application (2022-2027)
5.1.3 Global Influenza Vaccine Sales Market Share by Application (2016-2027)
5.2 Global Influenza Vaccine Revenue by Application
5.2.1 Global Influenza Vaccine Historical Revenue by Application (2016-2021)
5.2.2 Global Influenza Vaccine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
5.3 Global Influenza Vaccine Price by Application
5.3.1 Global Influenza Vaccine Price by Application (2016-2021)
5.3.2 Global Influenza Vaccine Price Forecast by Application (2022-2027)
6 North America
6.1 North America Influenza Vaccine Market Size by Type
6.1.1 North America Influenza Vaccine Sales by Type (2016-2027)
6.1.2 North America Influenza Vaccine Revenue by Type (2016-2027)
6.2 North America Influenza Vaccine Market Size by Application
6.2.1 North America Influenza Vaccine Sales by Application (2016-2027)
6.2.2 North America Influenza Vaccine Revenue by Application (2016-2027)
6.3 North America Influenza Vaccine Market Size by Country
6.3.1 North America Influenza Vaccine Sales by Country (2016-2027)
6.3.2 North America Influenza Vaccine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Influenza Vaccine Market Size by Type
7.1.1 Europe Influenza Vaccine Sales by Type (2017-2027)
7.1.2 Europe Influenza Vaccine Revenue by Type (2017-2027)
7.2 Europe Influenza Vaccine Market Size by Application
7.2.1 Europe Influenza Vaccine Sales by Application (2017-2027)
7.2.2 Europe Influenza Vaccine Revenue by Application (2017-2027)
7.3 Europe Influenza Vaccine Market Size by Country
7.3.1 Europe Influenza Vaccine Sales by Country (2017-2027)
7.3.2 Europe Influenza Vaccine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Influenza Vaccine Sales by Type (2018-2027)
8.1.2 Asia Pacific Influenza Vaccine Revenue by Type (2018-2027)
8.2 Asia Pacific Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Influenza Vaccine Sales by Application (2018-2027)
8.2.2 Asia Pacific Influenza Vaccine Revenue by Application (2018-2027)
8.3 Asia Pacific Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Influenza Vaccine Sales by Region (2018-2027)
8.3.2 Asia Pacific Influenza Vaccine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Influenza Vaccine Market Size by Type
9.1.1 Latin America Influenza Vaccine Sales by Type (2019-2027)
9.1.2 Latin America Influenza Vaccine Revenue by Type (2019-2027)
9.2 Latin America Influenza Vaccine Market Size by Application
9.2.1 Latin America Influenza Vaccine Sales by Application (2019-2027)
9.2.2 Latin America Influenza Vaccine Revenue by Application (2019-2027)
9.3 Latin America Influenza Vaccine Market Size by Country
9.3.1 Latin America Influenza Vaccine Sales by Country (2019-2027)
9.3.2 Latin America Influenza Vaccine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Influenza Vaccine Market Size by Type
6.1.1 Middle East and Africa Influenza Vaccine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Influenza Vaccine Revenue by Type (2016-2027)
6.2 Middle East and Africa Influenza Vaccine Market Size by Application
6.2.1 Middle East and Africa Influenza Vaccine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Influenza Vaccine Revenue by Application (2016-2027)
6.3 Middle East and Africa Influenza Vaccine Market Size by Country
6.3.1 Middle East and Africa Influenza Vaccine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Influenza Vaccine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Influenza Vaccine Product Description
11.1.5 CSL Related Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 GSK Influenza Vaccine Product Description
11.2.5 GSK Related Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Sanofi Pasteur Influenza Vaccine Product Description
11.3.5 Sanofi Pasteur Related Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Mylan Influenza Vaccine Product Description
11.4.5 Mylan Related Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 AstraZeneca Influenza Vaccine Product Description
11.5.5 AstraZeneca Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Pfizer Influenza Vaccine Product Description
11.6.5 Pfizer Related Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Johnson & Johnson Influenza Vaccine Product Description
11.7.5 Johnson & Johnson Related Developments
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Influenza Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Influenza Vaccine Product Description
11.1.5 CSL Related Developments
12 Value Chain and Sales Channels Analysis
12.1 Influenza Vaccine Value Chain Analysis
12.2 Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Influenza Vaccine Production Mode & Process
12.4 Influenza Vaccine Sales and Marketing
12.4.1 Influenza Vaccine Sales Channels
12.4.2 Influenza Vaccine Distributors
12.5 Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Influenza Vaccine Industry Trends
13.2 Influenza Vaccine Market Drivers
13.3 Influenza Vaccine Market Challenges
13.4 Influenza Vaccine Market Restraints
14 Key Findings in The Global Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Whole Virus Vaccines
Table 3. Major Manufacturers of Split Virus Vaccines
Table 4. Major Manufacturers of Subunit Vaccines
Table 5. Major Manufacturers of Live Attenuated Virus Vaccines
Table 6. Global Influenza Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Influenza Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 9. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 10. Global Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 11. Global Influenza Vaccine Sales Market Share by Region (2022-2027)
Table 12. Global Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 14. Global Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Influenza Vaccine Revenue Market Share by Region (2022-2027)
Table 16. Global Influenza Vaccine Sales by Manufacturers (2016-2021) & (K Doses)
Table 17. Global Influenza Vaccine Sales Share by Manufacturers (2016-2021)
Table 18. Global Influenza Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Influenza Vaccine Revenue Share by Manufacturers (2016-2021)
Table 20. Influenza Vaccine Price by Manufacturers 2016-2021 (USD/Doses)
Table 21. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2020)
Table 23. Influenza Vaccine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Influenza Vaccine Product Offered
Table 25. Date of Manufacturers Enter into Influenza Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 28. Global Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 29. Global Influenza Vaccine Sales Share by Type (2016-2021)
Table 30. Global Influenza Vaccine Sales Share by Type (2022-2027)
Table 31. Global Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Influenza Vaccine Revenue Share by Type (2016-2021)
Table 34. Global Influenza Vaccine Revenue Share by Type (2022-2027)
Table 35. Influenza Vaccine Price by Type (2016-2021) & (USD/Doses)
Table 36. Global Influenza Vaccine Price Forecast by Type (2022-2027) & (USD/Doses)
Table 37. Global Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 38. Global Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 39. Global Influenza Vaccine Sales Share by Application (2016-2021)
Table 40. Global Influenza Vaccine Sales Share by Application (2022-2027)
Table 41. Global Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Influenza Vaccine Revenue Share by Application (2016-2021)
Table 44. Global Influenza Vaccine Revenue Share by Application (2022-2027)
Table 45. Influenza Vaccine Price by Application (2016-2021) & (USD/Doses)
Table 46. Global Influenza Vaccine Price Forecast by Application (2022-2027) & (USD/Doses)
Table 47. North America Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 48. North America Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 49. North America Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 52. North America Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 53. North America Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 56. North America Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
Table 57. North America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 60. Europe Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 61. Europe Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 64. Europe Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 65. Europe Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 68. Europe Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
Table 69. Europe Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 72. Asia Pacific Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 73. Asia Pacific Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 76. Asia Pacific Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 77. Asia Pacific Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 80. Asia Pacific Influenza Vaccine Sales by Region (2022-2027) & (K Doses)
Table 81. Asia Pacific Influenza Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Influenza Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 84. Latin America Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 85. Latin America Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 88. Latin America Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 89. Latin America Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 92. Latin America Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
Table 93. Latin America Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 96. Middle East and Africa Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 97. Middle East and Africa Influenza Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Influenza Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 100. Middle East and Africa Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 101. Middle East and Africa Influenza Vaccine Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Influenza Vaccine Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 104. Middle East and Africa Influenza Vaccine Sales by Country (2022-2027) & (K Doses)
Table 105. Middle East and Africa Influenza Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Influenza Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 107. CSL Corporation Information
Table 108. CSL Description and Major Businesses
Table 109. CSL Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 110. CSL Influenza Vaccine Product
Table 111. CSL Recent Developments
Table 112. GSK Corporation Information
Table 113. GSK Description and Major Businesses
Table 114. GSK Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 115. GSK Influenza Vaccine Product
Table 116. GSK Recent Developments
Table 117. Sanofi Pasteur Corporation Information
Table 118. Sanofi Pasteur Description and Major Businesses
Table 119. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 120. Sanofi Pasteur Influenza Vaccine Product
Table 121. Sanofi Pasteur Recent Developments
Table 122. Mylan Corporation Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 125. Mylan Influenza Vaccine Product
Table 126. Mylan Recent Developments
Table 127. AstraZeneca Corporation Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 130. AstraZeneca Influenza Vaccine Product
Table 131. AstraZeneca Recent Developments
Table 132. Pfizer Corporation Information
Table 133. Pfizer Description and Major Businesses
Table 134. Pfizer Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 135. Pfizer Influenza Vaccine Product
Table 136. Pfizer Recent Developments
Table 137. Johnson & Johnson Corporation Information
Table 138. Johnson & Johnson Description and Major Businesses
Table 139. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2016-2021)
Table 140. Johnson & Johnson Influenza Vaccine Product
Table 141. Johnson & Johnson Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Influenza Vaccine Distributors List
Table 145. Influenza Vaccine Customers List
Table 146. Influenza Vaccine Market Trends
Table 147. Influenza Vaccine Market Drivers
Table 148. Influenza Vaccine Market Challenges
Table 149. Influenza Vaccine Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Market Share by Type in 2020 & 2027
Figure 3. Whole Virus Vaccines Product Picture
Figure 4. Split Virus Vaccines Product Picture
Figure 5. Subunit Vaccines Product Picture
Figure 6. Live Attenuated Virus Vaccines Product Picture
Figure 7. Global Influenza Vaccine Sales Market Share by Application in 2020 & 2027
Figure 8. For Children (6 months to 3 years)
Figure 9. For Adults and Children over 3 years
Figure 10. Influenza Vaccine Report Years Considered
Figure 11. Global Influenza Vaccine Sales 2016-2027 (K Doses)
Figure 12. Global Influenza Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Influenza Vaccine Revenue 2016-2027 (US$ Million)
Figure 14. Global Influenza Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Figure 16. Global Influenza Vaccine Sales Market Share by Region (2022-2027)
Figure 17. North America Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
Figure 18. North America Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
Figure 20. Europe Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
Figure 22. Asia-Pacific Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
Figure 24. Latin America Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Influenza Vaccine Sales YoY (2016-2027) & (K Doses)
Figure 26. Middle East & Africa Influenza Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Influenza Vaccine Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 29. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 31. Global Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 32. Global Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 33. Global Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 34. North America Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 35. North America Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 36. North America Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 37. North America Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 38. North America Influenza Vaccine Sales Share by Country (2016-2027)
Figure 39. North America Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 40. U.S. Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 43. Europe Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 44. Europe Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 45. Europe Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 46. Europe Influenza Vaccine Sales Share by Country (2016-2027)
Figure 47. Europe Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 48. Germany Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. France Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Influenza Vaccine Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Influenza Vaccine Revenue Share by Region (2016-2027)
Figure 59. China Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. India Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Taiwan Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 68. Philippines Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 70. Latin America Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 72. Latin America Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Influenza Vaccine Sales Share by Country (2016-2027)
Figure 74. Latin America Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 75. Mexico Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Influenza Vaccine Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Influenza Vaccine Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Influenza Vaccine Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Influenza Vaccine Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Influenza Vaccine Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Influenza Vaccine Revenue Share by Country (2016-2027)
Figure 84. Turkey Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. U.A.E Influenza Vaccine Revenue (2016-2027) & (US$ Million)
Figure 87. Influenza Vaccine Value Chain
Figure 88. Influenza Vaccine Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs